423768-52-9 Usage
Uses
Used in Pharmaceutical Industry:
(1,5-DIMETHYL-1H-PYRAZOL-3-YL)METHYLAMINE is used as an intermediate in the production of pharmaceuticals for its ability to contribute to the synthesis of various medicinal compounds, enhancing the development of new drugs and therapeutic agents.
Used in Agricultural Chemicals:
In the agricultural sector, (1,5-DIMETHYL-1H-PYRAZOL-3-YL)METHYLAMINE is used as an intermediate in the creation of agricultural chemicals, playing a role in the formulation of products that can improve crop protection and yield.
Used in Organic Synthesis:
(1,5-DIMETHYL-1H-PYRAZOL-3-YL)METHYLAMINE is utilized as a component in organic synthesis, where it serves as a building block for the assembly of more complex organic molecules, contributing to the advancement of organic chemistry and the creation of novel compounds.
Used as a Reagent in Chemical Reactions:
(1,5-DIMETHYL-1H-PYRAZOL-3-YL)METHYLAMINE is also employed as a reagent in various chemical reactions, facilitating specific transformations and processes that are essential in the synthesis of target molecules across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 423768-52-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,2,3,7,6 and 8 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 423768-52:
(8*4)+(7*2)+(6*3)+(5*7)+(4*6)+(3*8)+(2*5)+(1*2)=159
159 % 10 = 9
So 423768-52-9 is a valid CAS Registry Number.
InChI:InChI=1/C6H11N3/c1-5-3-6(4-7)8-9(5)2/h3H,4,7H2,1-2H3
423768-52-9Relevant academic research and scientific papers
BIOACTIVE COMPOUNDS FOR TREATMENT OF CANCER AND NEURODEGENERATIVE DISEASES
-
Page/Page column 129, (2009/12/23)
The invention provides bioactive compounds for the treatment of various malconditions such as cancer and neurodegenerative diseases including Alzheimer's disease. The chemical compounds as disclosed herein are found to show bioactivity in bioassays related to these conditions. Pharmaceutical compositions, combinations and methods of synthesis are provided, as are methods of using the compound, compositions and combinations in the treatment of the diseases.
